.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Fuji
Queensland Health
McKinsey
Covington
Chinese Patent Office
Federal Trade Commission
Cerilliant
Julphar
AstraZeneca

Generated: September 19, 2017

Patent: ► Subscribe

Summary for Patent: ► Subscribe

Title:Monoclonal antibodies against HER2 epitope and methods of use thereof
Abstract: This invention provides fully human monoclonal antibodies that recognize HER2. The invention further provides methods of using such monoclonal antibodies in a variety of therapeutic, diagnostic, and prophylactic indications.
Inventor(s): Bodyak; Natalya D. (Brookline, MA), DeVit; Michael J. (Sudbury, MA), Krauland; Eric M. (Lebanon, NH), Lowinger; Timothy B. (Carlisle, MA), Park; Peter U. (Somerville, MA), Prinz; Bianka (Lebanon, NH), Yurkovetskiy; Aleksandr V. (Littleton, MA)
Assignee: Mersana Therapeutics, Inc. (Cambridge, MA)
Application Number:14/742,947
Patent Claim Types:
see list of patent claims
Use;

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Inventors Patent Expiration Status Orphan Source
Genentech
HERCEPTIN
trastuzumab
VIAL; INTRAVENOUS1037920011998-09-25► Subscribe Mersana Therapeutics, Inc. (Cambridge, MA) Bodyak; Natalya D. (Brookline, MA), DeVit; Michael J. (Sudbury, MA), Krauland; Eric M. (Lebanon, NH), Lowinger; Timothy B. (Carlisle, MA), Park; Peter U. (Somerville, MA), Prinz; Bianka (Lebanon, NH), Yurkovetskiy; Aleksandr V. (Littleton, MA) ► SubscribeRXOrphansearch
Genentech
PERJETA
pertuzumab
VIAL; SINGLE-USE1254090012012-06-08► Subscribe Mersana Therapeutics, Inc. (Cambridge, MA) Bodyak; Natalya D. (Brookline, MA), DeVit; Michael J. (Sudbury, MA), Krauland; Eric M. (Lebanon, NH), Lowinger; Timothy B. (Carlisle, MA), Park; Peter U. (Somerville, MA), Prinz; Bianka (Lebanon, NH), Yurkovetskiy; Aleksandr V. (Littleton, MA) ► SubscribeRXsearch
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: ► Subscribe

Country Document Number Publication Date
African Regional IP Organization (ARIPO)201609656Dec 31, 2016
Argentina100969Nov 16, 2016
Australia2015277113Dec 15, 2016
Canada2950934Dec 23, 2015
Dominican RepublicP2016000315Feb 28, 2017
European Patent Office3157959Apr 26, 2017
South Korea20170020384Feb 22, 2017
Mexico2016016771Apr 04, 2017
Peru02642017Mar 19, 2017
Philippines12016502518Apr 10, 2017
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Moodys
Merck
Baxter
Harvard Business School
Boehringer Ingelheim
Deloitte
Accenture
Fuji
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot